1,121 results on '"Pierotti, Marco A."'
Search Results
252. Dotlike or Golgi-like KIT and PDGFRA Staining in GIST
253. Cancer and inflammation: A complex relationship
254. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
255. PDGFRA Immunostaining Can Help in the Diagnosis of Gastrointestinal Stromal Tumors
256. Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases
257. Subcellular Localization of Activated Leukocyte Cell Adhesion Molecule Is a Molecular Predictor of Survival in Ovarian Carcinoma Patients
258. Improvement of European Translational Cancer Research. Collaboration between Comprehensive Cancer Centers
259. Nanotechnology: Going Small for a Giant Leap in Cancer Diagnostics and Therapeutics
260. PIK3CAcancer mutations display gender and tissue specificity patterns
261. Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen
262. Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis
263. The role of chromosomal alterations in human cancer development
264. c-Kit/PDGFRA Gene Status Alterations Possibly Related to Primary Imatinib Resistance in Gastrointestinal Stromal Tumors
265. Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients
266. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/ penetrance studies.
267. Molecular and Biochemical Analyses of Platelet-Derived Growth Factor Receptor (PDGFR) B, PDGFRA, and KIT Receptors in Chordomas
268. Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma
269. International Agency for Research on Cancer Workshop on 'Expression array analyses in breast cancer taxonomy'
270. RET Is Constitutively Activated by Novel Tandem Mutations that Alter the Active Site Resulting in Multiple Endocrine Neoplasia Type 2B
271. Functional analysis and molecular modeling show a preserved wild-type activity of p53C238Y
272. The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF‐κB pathway
273. The RetC620R Mutation Affects Renal and Enteric Development in a Mouse Model of Hirschsprung's Disease
274. Phenotype–genotype correlation: Challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses
275. RESPONSE: Re: Limits of Predictive Models Using Microarray Data for Breast Cancer Clinical Treatment Outcome
276. Phosphatase Protein Homologue to Tensin Expression and Phosphatidylinositol-3 Phosphate Kinase Mutations in Colorectal Cancer
277. A Merging Duo in Melanoma Formation
278. Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
279. Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
280. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer
281. Proximity of TPR and NTRK1 Rearranging Loci in Human Thyrocytes
282. KIT/Val654Ala Receptor Detected in One Imatinib-Resistant GIST Patient
283. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized forc-kit and platelet-derived growth factor receptor α gene alterations
284. Detection of Overexpressed and Phosphorylated Wild-Type Kit Receptor in Surgical Specimens of Small Cell Lung Cancer
285. Imatinib mesylate in chordoma
286. APC Genotype Is Not a Prognostic Factor in Familial Adenomatous Polyposis Patients With Colorectal Cancer
287. Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2
288. Intragenic ERBB2 kinase mutations in tumours
289. Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching
290. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer
291. A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient
292. Different Genetic Features Associated with Colon and Rectal Carcinogenesis
293. BRAF alterations are associated with complex mutational profiles in malignant melanoma
294. 45th Annual Meeting of the Italian Cancer Society Bergamo, 9-12 November 2003
295. Biological Effects of the Dual Phenotypic Janus Mutation of ret Cosegregating with Both Multiple Endocrine Neoplasia Type 2 and Hirschsprung’s Disease
296. Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial Sarcoma
297. Correspondence re: T. Zhanget al ., Evidence That APC Regulates Survivin Expression: A Possible Mechanism Contributing to the Stem Cell Origin of Colon Cancer. Cancer Res.,61:8664–8667, 2001.
298. Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
299. The Molecular Basis of Thyroid Epithelial Tumorigenesis
300. Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified Mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.